These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 15791505

  • 1. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
    Reuter S, Kern WV, Sigge A, Döhner H, Marre R, Kern P, von Baum H.
    Clin Infect Dis; 2005 Apr 15; 40(8):1087-93. PubMed ID: 15791505
    [Abstract] [Full Text] [Related]

  • 2. Moxifloxacin prophylaxis in neutropenic patients.
    von Baum H, Sigge A, Bommer M, Kern WV, Marre R, Döhner H, Kern P, Reuter S.
    J Antimicrob Chemother; 2006 Oct 15; 58(4):891-4. PubMed ID: 16880172
    [Abstract] [Full Text] [Related]

  • 3. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
    Qin TJ, Mi YC, Feng SZ, Li DP, Wei JL, Yang DL, Han MZ, Wang JX, Bian SG.
    Zhonghua Yi Xue Za Zhi; 2007 May 29; 87(20):1389-93. PubMed ID: 17785058
    [Abstract] [Full Text] [Related]

  • 4. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
    Ugarte-Torres A, Villasis-Keever A, Hernández-Bribiesca ME, Crespo-Solis E, Ruiz-Palacios GM, Sifuentes-Osornio J, Ponce-De-León-Garduño A.
    Rev Invest Clin; 2006 May 29; 58(6):547-54. PubMed ID: 17432285
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
    Gomez L, Garau J, Estrada C, Marquez M, Dalmau D, Xercavins M, Martí JM, Estany C.
    Cancer; 2003 Jan 15; 97(2):419-24. PubMed ID: 12518366
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms.
    Rangaraj G, Granwehr BP, Jiang Y, Hachem R, Raad I.
    Cancer; 2010 Feb 15; 116(4):967-73. PubMed ID: 20052728
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.
    Kern WV, Klose K, Jellen-Ritter AS, Oethinger M, Bohnert J, Kern P, Reuter S, von Baum H, Marre R.
    Eur J Clin Microbiol Infect Dis; 2005 Feb 15; 24(2):111-8. PubMed ID: 15714332
    [Abstract] [Full Text] [Related]

  • 12. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
    Cullen M, Steven N, Billingham L, Gaunt C, Hastings M, Simmonds P, Stuart N, Rea D, Bower M, Fernando I, Huddart R, Gollins S, Stanley A, Simple Investigation in Neutropenic Individuals of the Frequency of Infection after Chemotherapy +/- Antibiotic in a Number of Tumours (SIGNIFICANT) Trial Group.
    N Engl J Med; 2005 Sep 08; 353(10):988-98. PubMed ID: 16148284
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia.
    Verlinden A, Jansens H, Goossens H, van de Velde AL, Schroyens WA, Berneman ZN, Gadisseur AP.
    Eur J Haematol; 2014 Oct 08; 93(4):302-8. PubMed ID: 24750350
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Ann Intern Med; 1991 Jul 01; 115(1):7-12. PubMed ID: 2048868
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study.
    Kjellander C, Björkholm M, Cherif H, Kalin M, Giske CG.
    Eur J Haematol; 2012 May 01; 88(5):422-30. PubMed ID: 22335785
    [Abstract] [Full Text] [Related]

  • 19. [Gram-negative bacteremia in neutropenic patients with hematologic disorders. Experiences with prophylactic use of fluoroquinolones].
    Sinkó J, Cser V, Konkoly Thege M, Masszi T.
    Orv Hetil; 2011 Jul 03; 152(27):1063-7. PubMed ID: 21676672
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.